Records containing: Sarcoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-06-26Phase II Study of Irinotecan (CPT-11) in Children and Adolescents With High Risk Ewing's Sarcoma
-
CLINICAL_TRIALS study record update · 2013-06-26A Phase II, Open-Label, Non-Randomized, Multicenter, Single Agent Study of Intravenous SDX-102 for the Treatment of Patients With MTAP-Deficient Cancer
-
CLINICAL_TRIALS study record update · 2013-06-26Study to Determine the Maximum Tolerated Time of Infusion for High-Dose Methotrexate, Administered as a Continuous Intravenous Infusion at a Dose of 6g/m² Per 24 Hours of Infusion Time
-
CLINICAL_TRIALS study record update · 2013-06-25Randomized Phase II Study of Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane With and Without ImmTher for Newly Diagnosed High Risk Ewing's Sarcoma
-
CLINICAL_TRIALS study record update · 2013-06-24Phase II Study of Trastuzumab (NSC-688097) in Treatment of Locally Advanced or Metastatic Synovial Sarcoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-06-24A Multi-Institutional, Open-Label, Phase II Study Of Doxorubicin And Bevacizumab (Anti-VEFG Monoclonal Antibody, NSC 704865) For Patients With Advanced Or Metastatic Soft-Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2013-06-24A Randomized Phase I/II Study Of Preoperative Radiotherapy With/Without SUGEN 5416 (NSC # 696819; A TK Inhibitor Anti-Angiogenesis Compound) In The Management Of Low To Intermediate Grade Soft Tissue Sarcoma Of The Trunk or Extremity
-
CLINICAL_TRIALS study record update · 2013-06-24Myeloablative Chemotherapy With Bone Marrow Rescue For Rare Poor-Prognosis Cancers
-
CLINICAL_TRIALS study record update · 2013-06-24A Phase I/II Study Of Neoadjuvant Chemotherapy, Angiogenesis Inhibitor SU5416 (NSC # 696819; A TK Inhibitor Anti-Angionesises Compound), And Radiation Therapy In The Management Of High Risk, High-Grade, Soft Tissue Sarcomas Of The Extremities And Body Wall
-
CLINICAL_TRIALS study record update · 2013-06-21Phase II Study of Recombinant Humanized Monoclonal Antibody Against HER2 for the Treatment of Recurrent Osteosarcoma
-
CLINICAL_TRIALS study record update · 2013-06-21Phase II Study of Thalidomide (NSC #66847) in Patients With Sarcomas of Gynecologic Origin
-
CLINICAL_TRIALS study record update · 2013-06-21A Phase II Window Study of Trimetrexate With Simultaneous Leucovorin Protection in the Treatment of Newly Diagnosed Patients With Metastatic Osteosarcoma
-
CLINICAL_TRIALS study record update · 2013-06-20PHASE II PROTOCOL WITH LABORATORY CORRELATES OF 1-[(S)-3-HYDROXY-2-(PHOSPHOMETHOXY)PROPYL]CYTOSINE DIHYDRATE(CIDOFOVIR) IN PATIENTS WITH KAPOSI'S SARCOMA (KS)
-
CLINICAL_TRIALS study record update · 2013-06-20Treatment of Classical Kaposi Sarcoma With Nicotine Dermal Patch: A Phase II Trial
-
CLINICAL_TRIALS study record update · 2013-06-20Phase II Study of Cyclophosphamide, Doxorubicin, Vincristine, Etoposide, and Ifosfamide, Followed by Resection and Radiotherapy in Patients With Peripheral Primitive Neuroectodermal Tumors or Ewing's Sarcoma
-
CLINICAL_TRIALS study record update · 2013-06-20A Phase I/II Trial of Temodar in Pediatric Patients and Young Adults With High-Risk or Recurrent Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-06-19A Phase II Study of Liposomal Doxorubicin and Interleukin-12 in AIDS-Associated Kaposi's Sarcoma Followed by Chronic Administration of Interleukin-12
-
CLINICAL_TRIALS study record update · 2013-06-19Phase II Trial of Gleevec (Formerly Known as STI571) in Patients With Soft Tissue and Bone Sarcomas: A Multi-Disciplinary Trial of the North American Sarcoma Study Group of the Connective Tissue Oncology Society
-
CLINICAL_TRIALS study record update · 2013-06-19An Open-Label, Intravenous To Oral Switch, Multiple Dose, Multi-Center Study To Investigate The Pharmacokinetics, Safety And Tolerability Of Voriconazole In Hospitalized Children Aged 2 - <12 Years Who Require Treatment For The Prevention Of Systemic Fungal Infection
-
CLINICAL_TRIALS study record update · 2013-06-19A Multicenter, Open, Non-Comparative, Sequential Dose-Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Two Separate Doses of MK-0991 in Children With New Onset Fever and Neutropenia
-
CLINICAL_TRIALS study record update · 2013-06-19Phase II Study of ET-743 Therapy in Metastatic Osteosarcoma
-
CLINICAL_TRIALS study record update · 2013-06-19A Phase II Trial of Active Specific Immunotherapy in Patients With Recurrent Soft Tissue Sarcoma Using Autologous Tumor-derived Heat Shock Protein-Peptide Complex (HSPPC-96)
-
CLINICAL_TRIALS study record update · 2013-06-10Evaluation of Doxil in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus
-
CLINICAL_TRIALS study record update · 2013-06-06A Multi-Institutional, Open-Label, Two-Group, Phase II Study of PS-341 (LDP-341, NSC #681239) in Patients With Advanced or Metastatic Sarcoma
-
CLINICAL_TRIALS study record update · 2013-06-03A Phase I Trial of EMD 121974 in Patients With HIV Related Kaposi's Sarcoma